Background: Early palliative care improves the quality of life (QoL) and satisfaction with care of patients with advanced cancer, but little is known about its effect on caregivers. Here, we report outcomes of caregiver satisfaction with care and QoL from a trial of early palliative care.
Introduction
Although the act of caregiving for patients with advanced cancer can lead to personal growth [1] [2] [3] , it may also result in distress that may exceed that of the patient [4] . Family caregivers describe numerous unmet needs in the provision of information about the patient's illness, prognosis and pain management, and addressing fears and concerns about the future [5, 6] . Interventions for caregivers may be directed specifically at the caregiver, at the patient-caregiver dyad, or more broadly at the patient and family [7] [8] [9] . The last approach is most common in palliative care, which is defined as a multidisciplinary approach that aims to relieve suffering, increase quality of life (QoL) and improve quality of care not only for patients but also for their families [10] .
Although palliative care was initially delivered mainly at the end of life, its initiation early in the course of advanced cancer improves numerous patient outcomes, including QoL, depression, satisfaction with care and, in some cases, survival [11] [12] [13] [14] . On this basis, it has been recommended that patients with advanced cancer should receive dedicated palliative care services, early in the disease course, concurrent with active treatment [15] . The early palliative care approach aims to improve patients' symptoms, attend to advance care planning, and assess and manage psychosocial needs of the patient and family [16] . This approach has the potential to improve caregivers' QoL and satisfaction with care through holistic care of patients and their caregivers [17] . However, to date, early palliative care studies assessing caregiver outcomes have been scarce, and results mixed [18, 19] .
We conducted a cluster randomised trial of early referral to palliative care versus standard oncology care in patients with advanced cancer and a prognosis of 6-24 months. We have previously reported primary and secondary outcomes for patients, which included improvements in QoL, symptom control and satisfaction with care [11] . Here, we report outcomes of family caregivers. We hypothesised that caregivers of patients receiving the early palliative care intervention would have improved QoL and satisfaction with care compared with caregivers receiving standard oncology care.
Methods

Design and participants
The cluster randomised trial design has been described previously [11] ; oncology clinics were the unit of randomisation and caregivers the units of inference for this substudy. All medical oncologists at the Princess Margaret Cancer Centre, Toronto, Canada, provided written consent to randomisation of their 24 oncology clinics to immediate consultation by palliative care or to the standard oncology care control group. Randomisation was conducted by the statistical team at Western University, Ontario, using a computergenerated sequence, and was stratified by clinic size and tumour site (lung, gastrointestinal, genitourinary, breast and gynaecological).
Recruitment involved regular, comprehensive screening of clinics by research personnel. Eligible patients had stage IV cancer (those with breast and prostate cancer had hormone-refractory disease), or stage III advanced cancer with poor prognosis; an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2; a clinical prognosis of 6-24 months (prognosis and ECOG were determined by the patient's primary medical oncologist); and passed a cognitive screen (Short Orientation-Memory-Concentration test >20 or <10 errors). Each patient was asked to identify their primary caregiver, who was approached with the patient's consent. Patients or caregivers were excluded if they were under 18 years old or had insufficient English literacy. Although full blinding was impossible, patients and caregivers consented to participation in their own trial group and were unaware of the existence of another group. The study was approved by the University Health Network Research Ethics Board and all participants provided written informed consent.
Intervention and control
The intervention group received palliative care alongside standard oncological care (supplementary Table S1 , available at Annals of Oncology online). The early palliative care intervention included consultation and monthly followup in the outpatient palliative care clinic by a palliative care physician and nurse [11, 16] . For the patient, this included symptom management, assessment of goals of care, advance care planning, and support of social, emotional and spiritual needs. For the caregiver, the focus was on providing social support, emotional care, and providing resources to assist with care of the patient. The nurse conducted follow-up phone calls a week after each visit; 24-h telephone support was provided by palliative care physicians. The presence of caregivers at visits was not mandatory. Ancillary interventions, depending on need, included home nursing, transfer of care to a home palliative care physician and access to an acute palliative care unit.
The control group received standard oncology care (supplementary Table  S1 , available at Annals of Oncology online). This included outpatient followup by an oncology physician and nurse, with frequency based on chemotherapy and radiation schedules [11] . There was no routine assessment of the psychosocial needs of the patient or caregiver [17] . Control patients could be referred to the palliative care team at any time, based on perceived need. Once referred, the patient received the same palliative care as the intervention group, though without the standardised monthly follow-up.
Measures
Research personnel collected demographic information, and distributed all caregiver-completed measures in person or by mail. Baseline information included the nature of the patient-caregiver relationship, time spent caregiving and assistance received. Patients' medical records were reviewed to verify cancer details. Caregivers completed measures of satisfaction with care and QoL at baseline and monthly for 4 months; analyses were pre-specified at 3 and 4 months. Caregivers who did not return forms within 2 weeks received a reminder telephone call; those who could not be reached were deemed lost to follow-up.
To assess satisfaction with care, caregivers completed the 19-item FAMCARE scale, which measures caregiver satisfaction with informationgiving, availability of care, and psychological and physical care of the advanced cancer patient. This measure has been validated in palliative settings and is sensitive to change [6, 20, 21] .
The SF-36v2 Health Survey was included as a measure of general QoL. This measure assesses QoL in domains of physical functioning, role limitation due to physical health problems, bodily pain, general health, vitality (energy/fatigue), social functioning and role limitation due to emotional/mental health [22] . It includes a physical component score (PCS) and a mental component score (MCS) and has been used previously to assess QoL in caregivers of patients with advanced cancer [23, 24] .
The Caregiver QoL Index-Cancer (CQoL-C) was included to assess whether there was an effect of the intervention specifically on QoL as it relates to caregiving for patients with cancer. It measures the effect of the patient's illness on the physical, emotional, social and family components of QoL for their caregivers, and has been validated in advanced cancer and palliative care settings [19, 25] .
Sample size and statistical analysis
The target patient sample size was 450 based on the primary trial outcome of patient QoL [26, 27] , taking into account the intracluster correlation coefficient and cluster size [11] . Caregivers were recruited until the patient sample was achieved. We used a multilevel linear random-intercept mixed-effect model, which took clustering into account, to test whether there was improvement in outcomes for caregivers in the intervention group compared with controls over 3 (primary end point) and 4 months (end of study). The primary analyses included all available data, with sensitivity analyses using multiple imputation for missing observations [28, 29] . Two types of multiple imputations were carried out: multiple imputation using the Markov Chain Monte Carlo (MCMC) method, and the pattern-mixture model approach, which accounts for potential non-random missingness. The number of imputations was set at 10. All analyses were by original assigned groups, following the intention to treat principle.
Results
Caregiver characteristics
Between December 2006 and February 2011, 182 primary caregivers [94 intervention (12 clinics), 88 control (11 clinics)] consented, completed baseline measures and were included in the analyses; 151 (77 intervention, 74 control) completed followup measures for at least one time point (Figure 1 ).
Caregivers were predominantly female and the caregiver for their spouse (Table 1) . Caregivers in both groups spent a mean of approximately 3 h per day on caregiving tasks. There were no substantive differences between the intervention and control groups for satisfaction with care (FAMCARE-19), health and functioning (SF-36v2), or QoL (CQoL-C) at baseline.
Attendance at the palliative care clinic
All patients in the intervention arm attended at least one palliative care clinic visit (median 4; range, 1-9); 85% of caregivers (n ¼ 80) in this group were present at one or more reviews (median 2, range 0-8). Ten control patients (11%) with nine control caregivers (10%) received palliative care review at Princess Margaret within the trial period. Figure 2 ). In the intervention group, the FAMCARE-19 score over time was not significantly associated with the number of palliative clinic visits attended by the caregiver (3 months: P ¼ 0.21, 4 months: P ¼ 0.39).
Satisfaction with care and QoL
There was no difference over time between the intervention and control groups over the trial period for the SF-36 PCS (3 months: P ¼ 0.83, 4 months: P ¼ 0.20), the SF-36 MCS (3 months: P ¼ 0.87, 4 months: P ¼ 0.60) or the CQoL-C (3 months: P ¼ 0.92, 4 months: P ¼ 0.51) ( Table 2) .
The sensitivity analyses demonstrated that the FAMCARE-19 difference was maintained at 3 and 4 months, using both MCMC and pattern-mixture multiple imputation (P 0.04 for all approaches) (supplementary Table S2 , available at Annals of Oncology online). The non-significant differences in the other outcomes (CQoL-C, SF-36 PCS and MCS) were also consistent across all approaches.
An exploratory analysis was undertaken to determine which items within the FAMCARE-19 measure demonstrated the most improvement over 3 months in the intervention group compared with controls. These were: how thoroughly the doctor assessed the patient's symptoms (P ¼ 0.004), availability of nurses to the Figure 1 . Trial profile.
family (P ¼ 0.01), information about the patient's tests (P ¼ 0.02) and referrals to other specialists (P ¼ 0.02).
Discussion
In this cluster randomised trial, early palliative care improved satisfaction with care in caregivers of patients with advanced cancer. These results complement our previously reported findings that early palliative care improved QoL and satisfaction with care in patients [11] , highlighting the shared experience of living with advanced cancer among patients and their caregivers, and adding to the body of evidence supporting early palliative care in the context of a diagnosis of advanced cancer [11] [12] [13] [14] . Results regarding QoL were inconclusive and this should remain an area of active investigation. Satisfaction with care is a marker of health care quality [30, 31] , and its improvement in the intervention group demonstrates an impact on the quality of care perceived by caregivers. This was demonstrated despite high baseline values compared with previous studies in advanced cancer [5, 21, 32, 33] . Improvement in satisfaction with care was unrelated to the number of palliative care visits attended by the caregiver. This may indicate that only minimal exposure to the clinic was necessary for this improvement; that it was mediated by care for the patient [34] ; or that it was also related to care outside the actual clinic, such as phone calls by physicians and nurses to caregivers between visits, and referrals to ancillary services. The domains of satisfaction with care that demonstrated the greatest improvement were the availability of care, the relay of information and attention to symptom control. The intervention addressed these domains through consistent support, a comprehensive team approach and use of validated symptom assessment tools [11, 16] . These results are in line with previous research showing that caregivers of patients with advanced illness value care that is accessible, coordinated, personalised and holistic [31] .
Despite improvements in satisfaction with care, we were unable to conclude whether early palliative care improved caregiver QoL. The potential impact may have been diluted by the smaller caregiver sample size, and by less frequent caregiver attendance at palliative care reviews. Caregiver QoL may also be related to influences such as the cost of care, which may require intervention at the level of the health care system rather for individuals. Previous trials assessing the effectiveness of caregiver interventions in the palliative phase have also not shown a substantial impact on QoL, although positive effects were found for depression, anxiety and stress burden [7, 8, 19] . This may indicate that current available measures for caregiver QoL do not capture potentially important differences. Interventions directed only at caregivers have the benefit of addressing issues that are specific to this group, but may not always be practical in the context of advanced cancer, due to the time commitment and cost they often entail [35, 36] . Further research is required in this regard.
Strengths of this trial include the recruitment of more than 180 caregivers, who were caring for patients with a diverse range of solid tumours, making this one of the largest studies assessing caregiver-specific outcomes [7-9, 18, 19] . Limitations include recruitment from a single cancer centre and that full blinding was not possible. There was a risk of selection bias inherent in the cluster randomised design, although this was taken into account for both design and analysis. The power calculation was patient rather than caregiver driven, and clinic attendance was less than for patients. The intervention was complex and there was no measurement of dosage of ancillary interventions. However, the core intervention of support by a physician and nurse was provided to 85% of caregivers in the intervention group; in qualitative interviews, caregivers described benefits of the intervention as resulting mainly from the overt focus on the family, feeling guided in their experience and preparation for the future [17, 37] . Qualitative interviews with caregivers specifically about their QoL are being analysed and may provide additional insight. Integrating early palliative care into the management of patients with advanced cancer is becoming the standard of care [15] . This study demonstrates that this approach also increases the satisfaction with care of their caregivers. It remains unclear whether this model of care improves caregiver QoL. Refining measures of QoL may enhance their sensitivity to detect the impact of an intervention. In addition, identifying which caregivers are most at risk of distress and burden could help direct more extensive and potentially costly caregiver-specific interventions to those with the greatest need. 
